{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464210715
| type              = mab
| image             = 
| alt               = 
| mab_type          = mab
| source            = zu/o
| target            = [[beta-amyloid]]
| tradename         =  
| Drugs.com         =
| MedlinePlus       =
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      = <!-- A / B            / C / D / X -->
| pregnancy_category=  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled -->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status      = 
| routes_of_administration = 
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| elimination_half-life = 
| excretion         = 
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number        = 1178862-65-1
| ATC_prefix        = none
| ATC_suffix        = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1TG15H1XE9
| PubChem           = 
| KEGG = D09952
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank          =
| C=6552 | H=10158 | N=1730 | O=2090 | S=52
| molecular_weight = 148.3 kg/mol
}}

'''Ponezumab''' is a humanized monoclonal antibody designed for the treatment of [[Alzheimer's disease]].<ref>{{cite web|title=Statement On A Nonproprietary Name Adopted By The USAN Council: Ponezumab|publisher=[[American Medical Association]]|url=http://www.ama-assn.org/resources/doc/usan/ponezumab.pdf}}</ref>

Ponezumab was developed by [[Pfizer]] Inc.
In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial.<ref>{{cite web|title=Alzforum|url=http://www.alzforum.org/new/detail.asp?id=2950}}</ref> Detailed reports have to be released.

== References ==
<references/>

{{Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems}}

[[Category:Pfizer products]]
[[Category:Treatment of Alzheimer's disease]]
[[Category:Experimental drugs]]


{{monoclonal-antibody-stub}}
{{nervous-system-drug-stub}}